Organization

Yokohama City University Hospital

2 abstracts

Abstract
Darolutamide for patients with androgen receptor positive salivary gland cancers (DISCOVARY): The results of phase 2 study of darolutamide monotherapy.
Org: National Cancer Center Hospital East, Kashiwa, Japan, Kobe University Hospital, National Hospital Organization Kyushu Medical Center, Osaka International Cancer Institute, Osaka, Japan, Tohoku University Hospital,
Abstract
The incidence of thyroid-related adverse events in solid tumors receiving immune checkpoint blockade with curative intent: A meta-analysis.
Org: Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, Mount Sinai Beth Israel, Yokohama City University Hospital, The Tisch Cancer Institute,